The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.

NCT02285634 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Epistaxis
Blood Pressure

Interventions

DRUG: Oxymetazoline 0.05%
DRUG: Phenylephrine 0.25%
DRUG: Lidocaine 1% plus epinephrine 1:100,000
DRUG: Bacteriostatic 0.9% NaCL

Sponsor

Mayo Clinic